Comprehensive Clinical and Pathological Analysis of Chondroblastic Osteosarcoma Masquerading as an Aneurysmal Bone Cyst in an Adolescent Patient: A Multidisciplinary Diagnostic Journey

Authors

  • Belinda Azhari Siswanto Universitas Brawijaya
  • Bima Mahardika Aji Universitas Brawijaya
  • Istan I. Irsan Universitas Brawijaya
  • Satria P. Persada Isma Universitas Brawijaya
  • Dandy D. Adiwignyo Universitas Brawijaya
  • Eviana Norahmawati Universitas Brawijaya

DOI:

https://doi.org/10.58344/locus.v5i5.5820

Keywords:

Chondroblastic Osteosarcoma, Aneurysmal Bone Cyst, SATB2, Immunohistochemistry, Adolescent Oncology, Proximal Femur

Abstract

Osteosarcoma is the most common primary malignant bone tumor, primarily affecting adolescents and young adults during periods of rapid skeletal growth. Chondroblastic osteosarcoma (COS) is a histological variant that poses a diagnostic challenge due to its extensive cartilaginous matrix, which can obscure the critical diagnostic feature: malignant osteoid production. This diagnostic complexity is further exacerbated when the tumor exhibits secondary aneurysmal bone cyst (ABC) changes, often leading to an initial misdiagnosis as a benign lesion. To analyze a case of chondroblastic osteosarcoma with secondary ABC changes, highlighting the importance of a multidisciplinary approach in diagnosing and managing high-grade bone tumors in adolescent patients. A case study of a 17-year-old male presenting with progressive pain and swelling in the right thigh. Diagnosis was confirmed through incisional biopsy, immunohistochemical profiling (positive for SATB2, P53, S100, and Osteocalcin), and MRI findings, which initially suggested an ABC. MRI findings indicated an aggressive bone tumor with fluid-fluid levels characteristic of ABC. However, after biopsy and immunohistochemical analysis, the final diagnosis was confirmed as high-grade chondroblastic osteosarcoma with secondary ABC changes. The patient underwent neoadjuvant MAP chemotherapy and limb-salvage surgery. This case underscores the importance of maintaining a high index of suspicion for malignancy in adolescent patients presenting with cystic bone lesions. A multidisciplinary approach involving clinical, radiological, and pathological correlation is crucial to prevent diagnostic delays and ensure the initiation of appropriate high-grade sarcoma therapy.

References

Yakushiji, T., Oka, K., Sato, H., Yorimitsu, S., Fujimoto, T., Yamashita, Y. and Mizuta, H. (2009), Characterization of chondroblastic osteosarcoma: Gadolinium-enhanced versus diffusion-weighted MR imaging. J. Magn. Reson. Imaging, 29: 895-900. https://doi.org/10.1002/jmri.21703

Capillary telangiectatic osteosarcoma misdiagnosed as aneurysmal bone cyst in a 12-year-old girl: A case report - NIH, diakses Februari 5, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC11995106/

Chondroblastic osteosarcoma - Autopsy and Case Reports, diakses Februari 5, 2026, https://autopsyandcasereports.org/article/doi/10.4322/acr.2023.466

Chondroblastic osteosarcoma - PMC - NIH, diakses Februari 5, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC10782518/

Aneurysmal bone cyst: a review - Journal of Pathology and Translational Medicine, diakses Februari 5, 2026, https://www.jpatholtm.org/journal/view.php?number=17061

Diagnosing and discriminating between primary and secondary aneurysmal bone cysts, diakses Februari 5, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC5403183/

Telangiectatic osteosarcoma versus aneurysmal bone cyst: a diagnostic challenge on small biopsy - ResearchGate, diakses Februari 5, 2026, https://www.researchgate.net/publication/395987940_Telangiectatic_osteosarcoma_versus_aneurysmal_bone_cyst_a_diagnostic_challenge_on_small_biopsy

(PDF) The differentiation between aneurysmal bone cyst and telangiectatic osteosarcoma: a clinical, radiographic and MRI study - ResearchGate, diakses Februari 5, 2026, https://www.researchgate.net/publication/340447589_The_differentiation_between_aneurysmal_bone_cyst_and_telangiectatic_osteosarcoma_a_clinical_radiographic_and_MRI_study

SATB2 immunohistochemistry in osteosarcoma: Utility in diagnosis and differentiation from histologic mimics | Request PDF - ResearchGate, diakses Februari 5, 2026, https://www.researchgate.net/publication/392522230_SATB2_immunohistochemistry_in_osteosarcoma_Utility_in_diagnosis_and_differentiation_from_histologic_mimics

The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas | Request PDF - ResearchGate, diakses Februari 5, 2026, https://www.researchgate.net/publication/304490597_The_utility_of_SATB2_immunohistochemical_expression_in_distinguishing_between_osteosarcomas_and_their_malignant_bone_tumor_mimickers_such_as_Ewing_sarcomas_and_chondrosarcomas

SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours - PubMed, diakses Februari 5, 2026, https://pubmed.ncbi.nlm.nih.gov/23701429/

Chemotherapy for Osteosarcoma - American Cancer Society, diakses Februari 5, 2026, https://www.cancer.org/cancer/types/osteosarcoma/treating/chemotherapy.html

KEPUTUSAN MENTERI KESEHATAN REPUBLIK INDONESIA NOMOR HK.01.07/MENKES/88/2019 TENTANG PEDOMAN NASIONAL PELAYANAN KEDOKTERAN TATA, diakses Februari 5, 2026, https://keslan.kemkes.go.id/unduhan/fileunduhan_1610416940_743550.pdf

Surgical Margin Analysis in Osteosarcoma: Impact on Survival and Local Control - NIH, diakses Februari 5, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC12345816/

Survival profiles and associated factors for overall and cancer specific survival in patients with chondroblast and fibroblastic osteosarcoma - PubMed Central, diakses Februari 5, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC12234990/

Clinical and Oncological Outcome of Chondroblastic Osteosarcoma: A Single Institutional Experience - PMC - NIH, diakses Februari 5, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC7429656/

Vertebral Aneurysmal Bone Cyst Mimicking Osteosarcoma: Case Report and Review of the Literature - PMC - NIH, diakses Februari 5, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC10023236/

Secondary Aneurysmal Bone Cyst Following Chondroblastoma of the Patella - PMC, diakses Februari 5, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC3804818/

Comparison of the Imaging and Pathological Features of Telangiectatic Osteosarcoma and Aneurysmal Bone Cyst of Long Tubular Bones - Brieflands, diakses Februari 5, 2026, https://brieflands.com/journals/ijradiology/articles/94686

Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology - PubMed, diakses Februari 5, 2026, https://pubmed.ncbi.nlm.nih.gov/40203873/

Chondroblastic Subtype Is Associated with Higher Rates of Local Recurrence in Skeletal Osteosarcoma - MDPI, diakses Februari 5, 2026, https://www.mdpi.com/2077-0383/14/22/7952

PNPK Osteosarkoma - Dr. Galih Endradita M, diakses Februari 5, 2026, https://galihendradita.wordpress.com/wp-content/uploads/2021/06/2017-pnpk-osteosarkoma.pdf

Current concepts in surgical treatment of osteosarcoma - PMC - PubMed Central, diakses Februari 5, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC3872798/

SOX9 and SATB2 Immunohistochemistry Cannot Reliably Distinguish Between Osteosarcoma and Chondrosarcoma on Biopsy Material | Request PDF - ResearchGate, diakses Februari 5, 2026, https://www.researchgate.net/publication/357721997_SOX9_and_SATB2_Immunohistochemistry_Cannot_Reliably_Distinguish_Between_Osteosarcoma_and_Chondrosarcoma_on_Biopsy_Material

Original Article Relationship between Ki-67 and P53 immunohistochemical expression and osteosarcoma chemotherapy sensitivity an - e-Century Publishing Corporation, diakses Februari 5, 2026, https://e-century.us/files/ajtr/17/10/ajtr0166366.pdf

ESMO Clinical Practice Guidelines: Sarcoma and GIST, diakses Februari 5, 2026, https://www.esmo.org/guidelines/esmo-clinical-practice-guidelines-sarcoma-and-gist

Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology., diakses Februari 5, 2026, https://discovery.researcher.life/article/bone-cancer-version-2-2025-nccn-clinical-practice-guidelines-in-oncology/614ff6275cc43f75934bc77cac5a445b

Treatment Name: MAP (Methotrexate + Doxorubicin + Cisplatin) - ChemoExperts, diakses Februari 5, 2026, https://www.chemoexperts.com/map-methotrexate-doxorubicin-cisplatin-sarcoma.html

Chondroblastic Subtype Is Associated with Higher Rates of Local Recurrence in Skeletal Osteosarcoma - ResearchGate, diakses Februari 5, 2026, https://www.researchgate.net/publication/397463681_Chondroblastic_Subtype_Is_Associated_with_Higher_Rates_of_Local_Recurrence_in_Skeletal_Osteosarcoma

Osteosarcoma: A Comprehensive Morphological and Molecular Review with Prognostic Implications - PMC - PubMed Central, diakses Februari 5, 2026,

Downloads

Published

2026-05-20